身体活动和心房动风险的25年轨迹:ARIC研究的结果
Tongxin Wang1, Xinyi Wang1, Tao Zhang2
1National Clinical Research Center for Chinese Medicine Cardiology, China Academy of Chinese Medical Sciences, Xiyuan Hospital, Haidian, Beijing, China.
Frontiers in cardiovascular medicine
|December 10, 2024
概括
保持适度的体力活动与心房动 (AF) 的风险降低有关. 活动水平下降会增加AF风险,这强调了持续炼对预防的重要性.
科学领域:
- 心脏病学 心脏病学
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 改变身体活动水平和心房动 (AF) 风险之间的联系尚未研究.
- 心房动是一种常见的心律障碍,对健康有重大影响.
研究的目的:
- 调查长期体育活动轨迹与心房的发病率之间的关联.
- 为了识别身体活动的不同模式,在20年内发生了变化.
主要方法:
- 在ARIC研究中利用了11,828名参与者的数据,在基线时无AF.
- 在三次访问期间 (1987-2013) 使用修改后的贝克问卷评估身体活动.
- 采用隐性类轨迹建模来定义身体活动模式和考克斯回归来分析AF发生率.
主要成果:
- 在24年的时间里,记录了2,108起发生的AF病例.
- 确定了四种身体活动轨迹:轻度,减轻中度,中度和强度.
- 与轻度活动组相比,中度活动的AF风险显著降低 (HR 0.61,95% CI 0.53-0.70),而中度活动减少的风险更高 (HR 1.18,95% CI 1.07-1.30).
结论:
- 维持适度的体力活动与患心房的风险降低有关.
- 身体活动的下降,特别是从中度到轻度的水平,会增加AF风险.
- 这些发现强调了持续体力活动在AF预防策略中的关键作用.
相关概念视频
Coronary Artery Disease IV: Preventive Measures
893
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
893
Acute Coronary Syndrome III: Diagnostic Studies
502
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
502
Atherosclerosis I: Introduction
2.5K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.5K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
961
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
961
Atherosclerosis III: Management
747
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747


